| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.2 | 5e-06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.086 | 0.08 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.08 | 0.09 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.08 | 0.09 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.078 | 0.1 |